ESTRO 2025 - Abstract Book

S1573

Clinical – Mixed sites & palliation

ESTRO 2025

Conclusion: The trial did not show a reduction in peak dysphagia with esophagus-sparing IMRT/VMAT, nor a change in ambulatory function between arms. However, a significant association was found between increased esophageal dose and risk of severe or worse dysphagia.

Keywords: Metastatic spinal cord compression,phase III trial

References: 1. Gram V, Fog LS, Hemer M, et al. Patient reported upper gastro-intestinal symptoms associated with fractionated image-guided conformal radiotherapy for metastatic spinal cord compression. Tech Innov Patient Support Radiat Oncol . 2020; 13:1-5. doi: 10.1016/j.tipsro.2019.11.008

3995

Digital Poster Radiotherapy for oligo-metastatic thymic tumours: an international experience. Marco Banini 1 , Emmanuelle Fabiano 2 , Antonin Levy 3 , Jordi Remon Masip 4 , Benjamin Besse 4 , Olaf Mercier 5 , Vieri Scotti 1 , Lorenzo Livi 1 , Cècile Le Péchoux 3 , Angela Botticella 3 1 Radiation Oncology, Azienda Ospedaliero Universitaria Careggi, Università di Firenze, Firenze, Italy. 2 Department of Radiation Oncology, Hôpital Européen Georges Pompidou, Paris, France. 3 Department of Radiation Oncology, Gustave Roussy, Villejuif, France. 4 Department of Medical Oncology, Gustave Roussy, Villejuif, France. 5 Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Institut d'Oncologie Thoracique, Marie Lannelongue Hospital, Le Plessis Robinson, France Purpose/Objective: Stereotactic Body Radiation Therapy (SBRT) is under investigation in prospective phase III clinical trials for patients with oligometastatic tumors in various histologies. Available literature on oligometastatic thymic tumors is limited.